Does immunosuppressive therapy improve outcomes in patients with virus-negative inflammatory cardiomyopathy?
Immunosuppressive therapy is efficacious in treating virus-negative inflammatory cardiomyopathy, although a small subset of patients may not respond.
These data confirm the efficacy of immunosuppression in virus-negative inflammatory cardiomyopathy. Lack of response in 12% of cases suggests the presence of not screened viruses or mechanisms of damage and inflammation not susceptible to immunosuppression.
Frustaci et al. (Thu,) studied this question.